Germacrone is a natural antiviral agent extracted from Rhizoma Curcuma with activity against porcine parvovirus (PPV).

Zanamivir (GR-121167X; GG-167; Relenza) is a novel and potent neuraminidase inhibitor with antiviral activity against influenza.

CBS1117 is a virus entry inhibitor with an IC50 of 70 nM for influenza A viruses, A/Puerto Rico/8/34 (H1N1). CBS1117 interferes with the hemagglutinin (HA)-mediated fusion process.

T-1105 (T1105), an analog of T-705 (favipiravir), is a novel and potent broad-spectrum antiviral inhibitor that inhibits the polymerases of RNA viruses after being converted to the actiive form: ribonucleoside triphosphate (RTP) metabolite.

Neuraminidase-IN-1， also known as Y-1, is a neuraminidase inhibitor, with an IC50 of 0.21 μM. Neuraminidase-IN-1 has excellent activity against H1N1 influenza virus and good inhibitory effect on the A/WSN/33 H1N1 virus strains.Y-1 exerts the best inhibition activity (IC50 = 0.21 μM) against NA, which is better than oseltamivir carboxylate (OSC) (IC50 = 3.04 μM) […]

Baloxavir (trade name Xofluza; also known as Baloxavir acid, BXA,or S-033447), derived from the prodrug baloxavir marboxil (BXM), is an orally available small molecule inhibitor of the cap-dependent endonuclease. It is an antiviral drug developed by Roche and Shionogi as an anti-influenza agent for treatment of influenza A and influenza B flu. As of 2018, […]

Cyclofenil (F-6066; AI3-52271) is a novel and potent gonadal stimulant and inducer of ovulation.

Thymalfasin is a novel and potent immunomodulating agent that is able to enhance the Thl immune response.

MBX-2329 HCl is a novel and potent inhibitor of influenza virus H1N1 hemagglutinin.

Cephalotaxine (Cephalotaxlen; ZINC-19795976) is a novel and potent antiviral agent with antitumor activity.